SCHEMBL6932648

SCHEMBL6932648

Cc1ccc(C(=O)Nc2nc3ccccc3n2CCN(C)C)cc1

nearest known ligand 0.82

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 9/20 0.82
ALDH1A1 P00352 5/20 0.82
HPGD P15428 4/20 0.82
TSHR P16473 4/20 0.77
MEN1 O00255 3/20 0.77
KMT2A Q03164 3/20 0.77
HTT P42858 2/20 0.77
HSD17B10 Q99714 2/20 0.77
SMN1; SMN2 Q16637 1/20 0.77
POLB P06746 2/20 0.71
OPRK1 P41145 4/20 0.70
RAB9A P51151 3/20 0.70
USP2 O75604 3/20 0.70
TP53 P04637 3/20 0.70
MAPK1 P28482 1/20 0.70
OPRM1 P35372 1/20 0.70
OPRD1 P41143 1/20 0.70
RXFP1 Q9HBX9 2/20 0.67
NPC1 O15118 1/20 0.67
NPSR1 Q6W5P4 3/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL6930439 0.91 KDM4E (0.81) KDM4EALDH1A1HPGDTSHRMEN1
SCHEMBL11715392 0.84 KDM4E (0.88) KDM4EALDH1A1HPGDTSHRMEN1
Dimethylamine SCHEMBL6932652 0.82 KDM4E (0.79) KDM4EALDH1A1HPGDTSHRMEN1
Hydrochloric Acid SCHEMBL11715153 0.82 KDM4E (0.84) KDM4EALDH1A1HPGDTSHRMEN1
SCHEMBL11718879 0.82 IRAK4 (0.79) KDM4EALDH1A1HPGDTSHRMEN1
SCHEMBL6933206 0.81 KDM4E (0.71) KDM4EALDH1A1HPGDTSHRMEN1
SCHEMBL25956639 0.79 IRAK4 (0.89) KDM4EALDH1A1HPGDPOLBIRAK4
Hydrochloric Acid SCHEMBL6929904 0.79 KDM4E (0.72) KDM4EALDH1A1HPGDTSHRMEN1
SCHEMBL20715608 0.79 NPC1 (0.70) ALDH1A1MEN1KMT2AHTTSMN1; SMN2
SCHEMBL11703846 0.76 KDM4E (1.00) KDM4EALDH1A1HPGDTSHRMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6660870-B1 Serotonergic compounds which possess agonist activity at 5-HT2 receptors effectively lower and control normal and elevated IOP and are useful for treating glaucoma ALCON, INC. (CH) 2003-12-09 US disclosed